C41H43N3O9 Cytidine, N-benzoyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O- (2-methoxyethyl)-5-methyl- (9CI, ACI) H335, H319, H315

NGĀ ATA KANAKA O=C1N=C(NC(=O)C=2C=CC=CC2)C(=CN1C3OC(COC(C=4C=CC=CC4)(C5=CC=C(OC)C=C5)C6 =CC=C(OC)C=C6)C(O)C3OCCOC)C
NGĀ ATA ISOMER
C(OC[C@H]1O[C@H]([C@H](OCCOC)[C@@H]1O)N2C(=O)N=C(NC(=O)C3=CC=CC =C3)C(C)=C2)(C4=CC=C(OC)C=C4)(C5=CC=C(OC)C=C5) C6=CC=CC=C6
InChI
InChI=1S/C41H43N3O9/c1-27-25-44(40(47)43-37(27)42-38(46)28-11-7-5-8-12-28)39-36(51- 24-23-48-2)35(45)34(53-39)26-52-41(29-13)
-9-6-10-14-29,30-15-19-32(49-3)20-16-30)31-17-21-33(50-4)22-18-31/h5-22 ,25,34-36,39,45H,23-24,26H2,1-4H3,(H,42,43,46,47)/t34-,3 5-,36-,39-/m1/s1
Kī InChI
BYSCLUAIKFEFAH-LZURGKRNSA-N
23 Ētahi atu Ingoa mō tēnei Matū
N-Benzoyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-5-methylcytidine (ACI); 10: PN: WO03084478 PAGE: 57 kerēme RNA; 12: PN: US20030170636 PAGE: 17 i kii R NA; 13: PN: US20030212017 PAGE: 19 i kii R NA; 14: PN: US20030

211606 PAGE: 19 i kii R NA; 15: PN: US20040005569 PAGE: 22 i kii R NA; 16: PN: US20040006030 PAGE: 22 i kii R NA; 16: PN: US20040014048 PAGE: 20 i kii R NA; 17: PN: US20030171313 PAGE: 9 i kii R NA; 17: PN: US20040005565 PAGE: 17- 22 kerēme RNA; 17: PN: US20040005570 PAGE: 20 i kii R NA; 17: PN: US20040014047 PAGE: 20 i kii R NA; 17: PN: US20040 014050 PAGE: 20 i kii R NA; 18: PN: US20030198965 PAGE: 19 i kii R NA; 18: PN: US20040014699 PAGE: 20 i kii R NA; 19: PN: US20040006029 PAGE: 23 i kii R NA; 19: PN: WO03106645 PAGE: 71 i kii R NA; 59: PN: US20030166592 PAGE: 15 kerēme RNA; 6: PN: WO2005006958 PAGE: 62 i kii R NA; 83: PN: US20040171566 PAGE: 18 i kii R NA; 8: PN: WO2005007825
PAGE: 62 i kii R NA; 90: PN: US20040005707 PAGE: 20 i kii R NA; N4-Benzoyl-2′-O-methoxyethyl-5′-O-dimethoxytriyl-5-
methylcytidine